bpc-157 is now available in capsule form Peptide Therapy BPC-157 (0.5mg/capsule), 60 Capsules -
Description
Concomitant medicines : Clinicians should review all concurrent medications, particularly insulin or sulfonylureas, given the potential for hypoglycaemia with incretin-based agents
Often only after a few months or even a year
Lyophilized BPC-157 must be stored at 20C before reconstitution
Den viktigste praktiske risikoen ved BPC-157 injeksjon er kontaminasjon
Dworkin RH, OConnor AB, Audette J, Baron R, Gourlay GK, Haanp ML, et al
Purity and Sterility Combat athletes injecting BPC-157 into their bodies must ensure the product is: Pure : Impurities can reduce efficacy or cause adverse reactions
